Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-052295
Filing Date
2010-10-04
Accepted
2010-10-04 18:36:59
Documents
1
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 v198201_ex.html 4  
1 v198201_ex.xml 4 3638
  Complete submission text file 0001144204-10-052295.txt   5500
Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121
Business Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 416 MARLBOROUGH STREET APT. 707 BOSTON MA 02115
Business Address
Gillespie Deirdre (Reporting) CIK: 0001354737 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 101107221